Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FREIHERR VON MALSON PONICKAU E
Original Assignee
FREIHERR VON MALSON PONICKAU E
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FREIHERR VON MALSON PONICKAU EfiledCriticalFREIHERR VON MALSON PONICKAU E
Priority to ES543080ApriorityCriticalpatent/ES8700317A1/en
Publication of ES8700317A1publicationCriticalpatent/ES8700317A1/en
Publication of ES543080A0publicationCriticalpatent/ES543080A0/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
Vaccines against diseases caused by pathogens in humans and other warm-blooded animals contain a form of the pathogen capable of living on protein from a non-warm-blooded animal (esp. fish protein). - Specifically the pathogens are Staphylococci, esp. S. aureus. - The parent strain is grown on a medium contg. fish protein, opt. while exposing the culture to mutagenic action, esp. UV radiation. Surviving colonies are isolated and the process is repeated several times. The final surviving cells are used directly for prodn. of live vaccines.